Revolution Medicine’s proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand prediction from Iambic.

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...

Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm as a strategic partner.

Farmabios is equipped with specialized facilities for cytotoxic and sterile processing and supply chain and warehousing capabilities.